The name CETERA arises from the Latin phrase “et cetera” – from et (and) + cetera (the other). A Contract Research Organization (CRO) is usually an independent party, which is hired to execute clinical trials. CETERA is a Portuguese academic CRO, located in Lisbon, with an unwavering commitment to quality and service flexibility. CETERA team brings essential expertise to support companies and research organizations successfully to solve today’s challenges in clinical research.
Portugal has an excellent geographical location. At the meeting point between three continents – Europe, Africa and America -, it has always been central to the most important international routes. On the other hand, Portuguese is becoming increasingly important. Spoken by about 230 million people, Portuguese is the sixth most widely spoken language in the world. It is the official language of eight countries. Portuguese is spoken all over the world – in Europe (Portugal and Portuguese islands), in Africa (Angola, Mozambique, Guinea-Bissau, São Tomé and Príncipe, Cape Verde), in Asia (East Timor, Macau, Goa) and of course in South America (Brazil).
The selection of our own staff is rigorous. CETERA team is made up of a group of experienced professionals with a strong scientific and academic background. Our multidisciplinary team brings various perspectives and insights to the study with a complete understanding of every stakeholder.
Research Team Network
CETERA is a pioneer academic CRO with a scientific advisory department with a medical and scientific team responsible of selecting and supporting principal investigators to warranty their motivation and commitment within the studies that CETERA is involved.
We are pioneering new ways of doing research focusing on the patient, research team, sites and optimizing access to clinical research. CETERA takes a very serious approach to being a partner, taking the time to fully understand the study objectives and overall needs.
Our commitment is providing the best consultancy and management in Clinical Research.
Together we can contribute significantly to the wellbeing of patients, giving an additional value to the health of the population.